Sage Journals: Discover world-class research

Open access

Review article

First published 2024

Outcomes of Emicizumab in Acquired Hemophilia Patients: A Systematic Review

Ghachem Ikbel, Baccouche Hela, Kaabar Mohamed Yassine [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Case report

First published 2021

Emicizumab in acquired haemophilia A: about two clinical cases and literature review

Amandine Hansenne, Cedric Hermans

Therapeutic Advances in Hematology

Open access

Case report

First published 2019

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays

Hande Kizilocak, Clara Lana Yukhtman, Elizabeth Marquez-Casas [...]

Therapeutic Advances in Hematology

Free access

Review article

First published 2018-10

The role of emicizumab,a bispecific factor IXa- and factor X-directed antibody,for the prevention of bleeding episodes in patients with hemophilia A

Tristan Knight, Michael U. Callaghan

Therapeutic Advances in Hematology

Open access

Research article

First published 2024

Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary

Carmen Escuriola Ettingshausen, Wolfgang Eberl, Hermann Eichler [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2022

Absence of Effect of Emicizumab on D-Dimer Concentrations in Adult Patients with Severe Hemophilia A

Michael Iarossi, Catherine Lambert, Cedric Hermans

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2019

Determining the value contribution of emicizumab (Hemlibra ® ) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Maria Teresa Álvarez-Román, Ignacio Cuervo-Arango, Rafael Pérez-Santamarina [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Case report

First published 2021

Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report

Louise Guillaume, Marie-Astrid van Dievoet, Catherine Lambert [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2022

Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy

Yuki Hatayama, Toru Motokura, Yuzuru Hosoda [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2026

Twelve-month follow-up of a real-world,noninterventional study evaluating the impact of emicizumab on bleeding episodes,joint health,and quality of life in people with hemophilia A

Anupam Dutta, Taniya Sarkar Dutta, Luish Borboruah [...]

Therapeutic Advances in Hematology

Search results